Welcome to the e-CCO Library!

search
Search by: 
Year: Category:
P913: Interactions between Intestinal Microbiota and micro-RNAs in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Eun, C.S.(1)*;Oh, E.H.(1);Lee, A.R.(1);Park, C.H.(1);Han , D.S.(1);
Created: Friday, 14 July 2023, 11:12 AM
P914: An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from infection by treatment with probiotic E. coli Nissle
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Nag, D.(1)*;Raychaudhuri, S.(2);Withey, J.(1);
Created: Friday, 14 July 2023, 11:12 AM
P915: Uncovering the role of Archaea in the pathogenesis of Inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Singh, P.(1);Murugesan, S.(1); Kumar, M.(1); Saadaoui, M.(1);Elhag, D.A.(1);Hendaus, M.A.(2); Ibrahim, N.(3); Al-Mudhaka, F.(3); AbuHazima, K.(3); Akobeng, A.(3);Elawad , M.(3);Al Khodor, S.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P916: Small bowel permeability improvement is associated with microbial changes seen in mild to moderate active paediatric Crohn's disease patients on nutritional therapy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: VerburgtMD, C.(1,2)*;Dunn, K.(3);Sigall Boneh, R.(4);Wine, E.(5);Benninga, M.(1);de Jonge, W.(2,6);Van Limbergen, J.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P917: Intestinal complement interacts with commensal microbiota and provides pattern recognition in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Reider, S.(1)*;Posch, W.(2);Koch, R.(3);Orth-Höller, D.(4);Würzner, R.(2);Wilflingseder, D.(2);Tilg, H.(3);Moschen, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P918: Clostridium butyricum inhibits epithelial-mesenchymal transition of intestinal carcinogenesis through downregulating METTL3
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zhang, K.(1)*;Dong, Y.(1);Li, M.(1);Zhang, W.(1);Ding, Y.(1);Wang, X.(1);Chen, D.(1);Liu, T.(1);Wang, B.(1);Zhong, W.(1);Cao, H.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P919: Gut microbial signature and phenotype-specific Indicators in fecal microbiota of Korean patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lee, C.K.(1)*;Oh, S.J.(1);Kim, H.J.(1);Kim, B.H.(2);Kim, B.K.(3);Park, Y.K.(3);Yang, B.G.(3);
Created: Friday, 14 July 2023, 11:12 AM
P920: Gut microbiota at diagnosis is associated with clinical features and future disease course in Inflammatory Bowel Disease: Data from IBSEN III, a new large Norwegian population-based inception cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hyll Hansen, S.(1,2,3)*;Gjerstad Maseng, M.(3,4,5);Björkqvist, O.(6);Halfvarsson, J.(7);Bang, C.(8);Detlie, T.E.(9,10);Huppertz-Hauss, G.(11);Kristensen, V.(5,12);Opheim, R.(5,13);Perminow, G.(14);Asak, Ø.(15);Bengtson, M.B.(10);Boyar Cetinkaya, R.(16);Henriksen, M.(17);Hovde, Ø.(3,18);Medhus, A.W.(3,5);Pallenschat, J.(19);Strande, V.(3,20,21);Valeur, J.(21);Svendsen Vatn, S.(10);Bergene Aabrekk, T.(22);Høivik, M.L.(5);Hov, J.R.(1,2,3,23);
Created: Friday, 14 July 2023, 11:12 AM
P921: FMT in UC is associated with a decrease in Bacteroides-2 enterotype and response with baseline RNA and microbiota signatures
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Deleu, S.(1)*;Caenepeel , C.(1);Verstockt, S.(1);Vazquez Castellanos, J.F.(2,3);Arnauts , K.(1);Braekeleire, S.(1);Machiels, K.(1);Baert, F.(4);Mana, F.(5);Pouillon, L.(6);Hindryckx, P.(7);Lobaton Ortega, T.(7);Louis, E.(8);Franchimont, D.(9);Verstockt , B.(1,10);Ferrante, M.(1,10);Sabino, J.(1,10);Vieira-Silva, S.(2,11,12);Falony, G.(2,3,13);Raes, J.(2,3);Vermeire, S.(1,10);
Created: Friday, 14 July 2023, 11:12 AM
P922: Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridium difficile infection
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yu, S.(1)*;Ge, X.(2);Tan, B.(1);Tian, B.(1);Shi, Y.(1);Dai, Y.(1);Hu, S.(3);Li, Y.(1);Qian, J.(1);
Created: Friday, 14 July 2023, 11:12 AM
P923: The pre-treatment gut microbiome at adult IBD inception: Initial signals from the Birmingham inception cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rimmer, P.(1)*;Cheesbrough, J.(1);Iqbal, A.(2);Sharma, N.(1);Iqbal, T.(1);Quraishi, N.(1);
Created: Friday, 14 July 2023, 11:12 AM
P924: A unique gut microbiome signature can help differentiate Crohn`s Disease and isolated Terminal Ileitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Raghunathan, N.(1)*;Joshi, V.(1);Patel, R.(1);Mekala, D.(1);Pal, P.(1);Banerjee, R.(1);
Created: Friday, 14 July 2023, 11:12 AM
P925: Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Teh, J.J.(1);Kang, S.(1);Zhang, J.(2,3,4);Hu, J.(2,3,4);Hamilton, A.L.(5,6);Wilson-O'Brien, A.(5,6);Trakman, G.L.(5,6);Lin, W.(2,3,4);Ching, J.(2,4);Sung, J.J.Y.(7);Yu, J.(2,4);Ng, S.C.(2,3,8);Kamm, M.A.(5,6)*;Morrison, M.(1);
Created: Friday, 14 July 2023, 11:12 AM
P926: Blautia Obeum Aggravates Colitis in a Murine Model
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lee, C.(1,2)*;Koh, S.J.(1,2);Hong, H.T.(1,2);Park, H.(2,3);Im, J.P.(1);Kim, J.S.(1);
Created: Friday, 14 July 2023, 11:12 AM
P927: Corticosteroid treatment in pediatric IBD patients reshapes the gut microbiota
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Singh , P.(1);Sundararajan, S.(2);Terranegra, A.(1);Elawad, M.(2);Akobeng, A.(2);Al Khodor, S.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P928: Identification of mucosal microbiome-host gene interactions in ulcerative colitis patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Namjoo, K.(1)*;Beom Jae Prof. Dr., L.(2);Jeong-An , G.(3);Seung Han, K.(1);Moon Kyung , J.(1);Jong-Jae , P.(1);
Created: Friday, 14 July 2023, 11:12 AM
P929: Gut mucosal microbiota composition in Inflammatory Bowel Disease introduced to infliximab
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ventin-Holmberg, R.(1)*;Lindholm, J.(2);Eberl, A.(3);Taina, S.(3);Saavalainen, P.(4);
Created: Friday, 14 July 2023, 11:12 AM
Paediatric CD Treatment e-Course
Year: 2020
Source: e-Course
Authors: Marco Gasparetto, Salvatore Oliva, Patrick van Rheenen
Created: Friday, 28 February 2020, 11:58 AM by Dauren Ramankulov
Last Modified: Friday, 13 January 2023, 12:34 PM by ECCO Administrator

This course has been developed by physicians who had recently participated in the writing of the ECCO Crohn's disease consensus Guidelines. This course is intended for those who are interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to Perianal disease in order to improve patient outcomes.

Upon completion of this case you will:

  • Recognise clinical red flags of paediatric Crohn's and achieve a timely diagnosis
  • Familiarise with the work-up required at IBD diagnosis, including ruling out differential diagnoses
  • Know the current evidence for induction of remission in paediatric Crohn's.
  • Know the current evidence for maintaining remission in paediatric Crohn's.
  • Know how to manage a Crohn's flare in a paediatric patient.
  • Familiarise with how to use immunomodulatory agents in mono or combination therapy and understand the rational behind therapeutic drug monitoring in paediatric Crohn's.
  • Recognise indications for surgical management of paediatric Crohn's and familiarise with the recommended post-operative monitoring.

Paediatric IBD - clinical aspects
Year: 2019
Source: 4th H-ECCO IBD Masterclass
Authors: Patrick van Rheenen
Created: Tuesday, 28 May 2019, 3:32 PM
Paediatric
Files: 1
Paediatric IBD - pathological features
Year: 2019
Source: 4th H-ECCO IBD Masterclass
Authors: Paula Borralho Nunes
Created: Tuesday, 28 May 2019, 3:32 PM
Paediatric
Files: 1